文献速递衰弱、肌少症与跌倒老年慢病共病管理

B期心衰老年患者肌少症患病率及预后意义

Prevalence and Prognostic Implication of Sarcopenia Among Patients With Stage B Heart Failure: The PAPRIKA-HF Cohort Study.
PubMed 文献 · J Am Geriatr Soc · 2025-08-29

PAPRIKA-HF多中心前瞻性研究纳入312例≥65岁B期心衰门诊患者,按AWGS 2019标准评估肌少症。17.7%存在肌少症,其2年复合终点(全因死亡、心梗或心衰住院)发生率显著更高(25.0% vs 2.7%),肌少症为独立预后预测因子(HR 5.78)。

要点

  • B期心衰老年门诊患者肌少症患病率为17.7%。
  • 肌少症患者2年复合终点发生率25.0%,显著高于无肌少症者2.7%。
  • 肌少症是长期预后独立预测因子(HR 5.78,95%CI 2.16-15.43)。

核心结论

  • 在≥65岁B期心衰患者中,肌少症与更差的长期预后相关,提示早期诊断肌少症的重要性。

研究设计与样本

  • PAPRIKA-HF为多中心前瞻性研究,纳入≥65岁确诊B期心衰的门诊患者312例(平均年龄78.2±6.5岁,45%女性)。
  • 肌少症依据亚洲肌少症工作组(AWGS)2019诊断标准评估,主要终点为>2年复合终点(全因死亡、新发心肌梗死或心衰住院)。

主要发现

  • 312例患者中17.7%(56/312)存在肌少症。
  • 肌少症患者2年复合终点发生率为25.0%,无肌少症者为2.7%,log-rank检验p<0.0001。
  • 多因素Cox比例风险模型显示肌少症为长期预后的独立预测因子(HR 5.78,95%CI 2.16-15.43,p<0.001)。

关键数值与推荐

  • 肌少症诊断采用AWGS 2019标准。
  • 主要终点为>2年复合终点:全因死亡、新发心肌梗死或心衰住院。

临床怎么用

  • 对≥65岁B期心衰门诊患者应关注肌少症评估,按AWGS 2019标准早期识别肌少症以识别高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The long-term prognosis of patients with heart failure (HF) remains poor. Most patients with HF are older, and multiple factors involved in geriatric syndromes are associated with worse long-term prognosis. Sarcopenia is a major component of geriatric syndrome. Early diagnosis and therapeutic intervention for sarcopenia are clinically important in patients with HF; however, the prevalence and long-term prognostic impact of sarcopenia in patients with stage B HF remain unclear. This study aimed to determine the prevalence of sarcopenia in older patients with stage B HF and its impact on the long-term prognosis. METHODS: The PAPRIKA-HF study was a multicenter, prospective study that enrolled outpatients ≥ 65 years who were diagnosed with stage B HF. Sarcopenia was assessed based on the Asian Working Group for Sarcopenia 2019 diagnostic criteria. The primary endpoint was a composite endpoint (all-cause mortality, incident myocardial infarction, or hospitalization for heart failure) of > 2 years. RESULTS: Among 312 patients (mean age: 78.2 ± 6.5 years, 45% female), 17.7% (56 of 312 patients) had sarcopenia. The rate of the composite endpoint over 2 years was significantly higher in patients with sarcopenia than in those without (25.0% vs. 2.7%, log-rank test, p < 0.0001). Multivariate analysis using the Cox proportional hazards model showed that sarcopenia was an independent predictor of long-term prognosis (hazard ratio: 5.78, 95% confidence interval: 2.16-15.43, p < 0.001). CONCLUSIONS: Sarcopenia was associated with a worse long-term prognosis in older patients with stage B HF, highlighting the importance of early diagnosis of sarcopenia.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Matsumura K, Morishita S, Morimoto J, et al. Prevalence and Prognostic Implication of Sarcopenia Among Patients With Stage B Heart Failure: The PAPRIKA-HF Cohort Study. J Am Geriatr Soc. 2025. PMID: 40879204. doi:10.1111/jgs.70046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。